References
- PetersenRCSmithGEWaringSCIvnikRJTangalosEGKokmenEMild cognitive impairment: clinical characterization and outcomeArch Neurol199956330330810190820
- PetersenRCMild cognitive impairment as a diagnostic entityJ Intern Med2004256318319415324362
- MolanoJBoeveBFermanTMild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological studyBrain2010133Pt 254055619889717
- PetersenRCThomasRGGrundmanMAlzheimer’s Disease Cooperative Study GroupVitamin E and donepezil for the treatment of mild cognitive impairmentN Engl J Med2005352232379238815829527
- BusseAHenselAGühneUAngermeyerMCRiedel-HellerSGMild cognitive impairment: long-term course of four clinical subtypesNeurology200667122176218517190940
- Di CarloALamassaMBaldereschiMCIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementiaNeurology200768221909191617536047
- PlassmanBLLangaKMFisherGGPrevalence of cognitive impairment without dementia in the United StatesAnn Intern Med2008148642743418347351
- ManlyJJTangMXSchupfNSternYVonsattelJPMayeuxRFrequency and course of mild cognitive impairment in a multiethnic communityAnn Neurol200863449450618300306
- LopezOLJagustWJDeKoskySTPrevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1Arch Neurol200360101385138914568808
- PetersenRCRobertsROKnopmanDSPrevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of AgingNeurology2010751088989720820000
- AndertonBHAging of the brainMech Aging Dev2002123781181711869738
- FariasSTMungasDReedBRHarveyDDeCarliCProgression of mild cognitive impairment to dementia in clinic- vs community-based cohortsArch Neurol20096691151115719752306
- GanguliMChangCCSnitzBESaxtonJAVanderbiltJLeeCWPrevalence of mild cognitive impairment by multiple classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) projectAm J Geriatr Psychiatry201018867468320220597
- BhattacharyaSKBhattacharyaAKumarAGhosalSAntioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampusPhytother Res200014317417910815010
- ChowdhuriDKParmarDKakkarPShuklaRSethPKSrimalRCAntistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brainPhytother Res200216763964512410544
- RussoABorrelliFCampisiAAcquavivaRRacitiGVanellaANitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monnieraLife Sci200373121517152612865091
- RussoAIzzoAABorrelliFRenisMVanellaAFree radical scavenging capacity and protective effect of Bacopa monniera L. on DNA damagePhytother Res200317887087513680815
- PaseMPKeanJSarrisJNealeCScholeyABStoughCThe cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trialsJ Altern Complement Med201218764765222747190
- McNultyHPByunJLockwoodSFJacobRFMasonRPDifferential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysisBiochim Biophys Acta20071768116717417070769
- IwamotoTHosodaKHiranoRInhibition of low-density lipoprotein oxidation by astaxanthinJ Atheroscler Thromb20007421622211521685
- ParkJSChyunJHKimYKLineLLChewBPAstaxanthin decreased oxidative stress and inflammation and enhanced immune response in humansNutr Metab (Lond)201071820205737
- WolfAMAsohSHiranumaHAstaxanthin protects mitochondrial redox state and functional integrity against oxidative stressJ Nutr Biochem201021538138919423317
- SatohATsujiSOkadaYPreliminary clinical evaluation of toxicity and efficacy of a new astaxanthin-rich Haematococcus pluvialis extractJ Clin Biochem Nutr200944328028419430618
- AlbertsBJohnsonALewisJRaffMRobertsKWalterPMolecular Biology of the Cell4th edNew York, NYGarland Science2002
- KiddPMPS (Phosphatidyl Serine), Nature’s Brain Booster2nd edSt George, UTTotal Health Communications2007
- ToffanoGThe therapeutic value of phosphatidylserine effect in the aging brainHaninLAnsellGBLecithin: TechnologicalBiological and Therapeutic AspectsNew YorkPlenum Press1987137146
- NunziMGMilanFGuidolinEZanottiAToffanoGTherapeutic properties of phosphatidylserine in the aging brainHaninIPepeuGPhospholipids: Biochemical, Pharmaceutical and Analytical ConsiderationsNew YorkPlenum Press1990213218
- SamsonJCThe biological basis of phosphatidylserine pharmacologyClin. Trials J198724118
- BorgheseCMGómezRARamírezOAPhosphatidylserine increases hippocampal synaptic efficacyBrain Res Bull19933166977008100181
- ToffanoGBruniAPharmacological properties of phospholipid liposomesPharmacol Res Commun19801298298456108574
- JoshiYBPraticòDVitamin E in aging, dementia, and Alzheimer’s diseaseBiofactors2012382909722422715
- FolsteinMFFolsteinSEMcHughPR“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
- RosenWGMohsRCDavisKLA new rating scale for Alzheimer’s diseaseAm J Psychiatry198414111135613646496779
- LibonDJSwensonRBaronskiEJSandsLPClock drawing as an assessment tool for dementiaArch Clin Neuropsychol19938540541514589710
- RozziniLVicini ChiloviBBertolettiEThe importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer diseaseJ Geriatr Psychiatry Neurol200821426126719017783
- CooperCLiRLyketsosCLivingstonGTreatment for mild cognitive impairment: systematic reviewBr J Psychiatry201320325526424085737